Redox regulation of cysteine-dependent enzymes in neurodegeneration

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Guttmann, Rodney P ^a   Powell, Tamara J ^a  

^a UNIVERSITY OF WEST FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CATHEPSIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTEINE; DJ 1 PROTEIN; GLUTATHIONE; PEROXIREDOXIN 2; PROTEIN DISULFIDE ISOMERASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; BRAIN; CANCER GROWTH; CYTOSOL; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; HUMAN; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

EID: 84864960620     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/703164     Document Type: Review

References (69)

1. Pandya R. S., Mao L. L. J., Zhou E. W., Bowser R., Zhu Z., Zhu Y., Wang X., Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy Central Nervous System Agents in Medicinal Chemistry 2012 12 1 15 27
2. Surmeier D. J., Guzman J. N., Sanchez-Padilla J., Goldberg J. A., The origins of oxidant stress in parkinson's disease and therapeutic strategies Antioxidants and Redox Signaling 2011 14 7 1289 1301
3. Sayre L. M., Smith M. A., Perry G., Chemistry and biochemistry of oxidative stress in neurodegenerative disease Current Medicinal Chemistry 2001 8 7 721 738 (Pubitemid 32427903)
4. Clark T. A., Lee H. P., Rolston R. K., Zhu X., Marlatt M. W., Castellani R. J., Nunomura A., Casadesus G., Smith M. A., Lee H. G., Perry G., Oxidative stress and its implications for future treatments and management of Alzheimer disease International Journal of Biomedical Science 2010 6 3 225 227
5. Wang Y., Yang J., Yi J., Redox sensing by proteins: oxidative modifications on cysteines and the consequent events Antioxidants and Redox Signaling 2012 16 7 649 657
6. Lushchak V. I., Adaptive response to oxidative stress: bacteria, fungi, plants and animals Comparative Biochemistry and Physiology 2011 153 2 175 190
7. Ooe H., Iguchi-Ariga S. M. M., Ariga H., Establishment of specific antibodies that recognize C106-oxidized DJ-1 Neuroscience Letters 2006 404 1-2 166 169 (Pubitemid 44041785)
8. Hu J., Zhang Z., Shen W.-J., Nomoto A., Azhar S., Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI Biochemistry 2011 50 50 10860 10875
9. Aracena-Parks P., Goonasekera S. A., Gilman C. P., Dirksen R. T., Hidalgo C., Hamilton S. L., Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1 The Journal of Biological Chemistry 2006 281 52 40354 40368 (Pubitemid 46043301)
10. Jordans S., Jenko-Kokalj S., Khl N. M., Tedelind S., Sendt W., Brmme D., Turk D., Brix K., Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions BMC Biochemistry 2009 10 1, article 23
11. Jomova K., Valko M., Advances in metal-induced oxidative stress and human disease Toxicology 2011 283 2-3 65 87
12. Spivey A., Rotenone and paraquat linked to Parkinson's Disease: human exposure study supports years of animal studies Environmental Health Perspectives 2011 119 6, article A259
13. Olanow C. W., A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease Movement Disorders 1993 8 1, supplement S1 S7
14. Cochemé H. M., Murphy M. P., Complex I is the major site of mitochondrial superoxide production by paraquat The Journal of Biological Chemistry 2008 283 4 1786 1798
15. Pitkanen S., Robinson B. H., Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase The Journal of Clinical Investigation 1996 98 345 351 (Pubitemid 26255732)
16. Treberg J. R., Quinlan C. L., Brand M. D., Evidence for two sites of superoxide production by mitochondrial NADH-ubiquinone oxidoreductase (complex I) The Journal of Biological Chemistry 2011 286 31 27103 27110
17. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B., Smith M. A., Oxidative damage is the earliest event in Alzheimer disease Journal of Neuropathology and Experimental Neurology 2001 60 8 759 767 (Pubitemid 32678256)
18. Garg S. K., Vitvitsky V., Albin R., Banerjee R., Astrocytic redox remodeling by amyloid beta peptide Antioxidants and Redox Signaling 2011 14 12 2385 2397
19. Ansari M. A., Scheff S. W., Oxidative stress in the progression of alzheimer disease in the frontal cortex Journal of Neuropathology and Experimental Neurology 2010 69 2 155 167
20. Hall A., Karplus P. A., Poole L. B., Typical 2-Cys peroxiredoxinsstructures, mechanisms and functions FEBS Journal 2009 276 9 2469 2477
21. Reed T. T., Pierce W. M. Jr., Turner D. M., Markesbery W. R., Allan Butterfield D., Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule Journal of Cellular and Molecular Medicine 2009 13 8 2019 2029
22. Cumming R. C., Dargusch R., Fischer W. H., Schubert D., Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid -resistant nerve cells The Journal of Biological Chemistry 2007 282 42 30523 30534 (Pubitemid 350035173)
23. Fang J., Nakamura T., Cho D. H., Gu Z., Lipton S. A., S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18742 18747 (Pubitemid 350210767)
24. Honjo Y., Ito H., Horibe T., Takahashi R., Kawakami K., Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease Brain Research 2010 1349 90 96
25. Uehara T., Nakamura T., Yao D., Shi Z. Q., Gu Z., Ma Y., Masliah E., Nomura Y., Lipton S. A., S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration Nature 2006 441 7092 513 517 (Pubitemid 44050153)
26. Goll D. E., Thompson V. F., Li H., Wei W., Cong J., The calpain system Physiological Reviews 2003 83 3 731 801 (Pubitemid 36828925)
27. Storr S. J., Carragher N. O., Frame M. C., Parr T., Martin S. G., The calpain system and cancer Nature Reviews Cancer 2011 11 5 364 374
28. Guttmann R. P., Elce J. S., Bell P. D., Clay Isbell J., Johnson G. V. W., 'Oxidation inhibits substrate proteolysis by calpain I but not autolysis The Journal of Biological Chemistry 1997 272 3 2005 2012 (Pubitemid 27043298)
29. Guttmann R. P., Johnson G. V. W., Oxidative stress inhibits calpain activity in situ The Journal of Biological Chemistry 1998 273 21 13331 13338 (Pubitemid 28246908)
30. Marcum J. L., Mathenia J. K., Chan R., Guttmann R. P., Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease Biochemical and Biophysical Research Communications 2005 334 2 342 348 (Pubitemid 40984028)
31. Lesage S., Brice A., Parkinson's disease: from monogenic forms to genetic susceptibility factors Human Molecular Genetics 2009 18 1 R48 R59
32. Cheng H., Wang L., Wang C. C., Domain a of protein disulfide isomerase plays key role in inhibiting -synuclein fibril formation Cell Stress and Chaperones 2010 15 4 415 421
33. Conn K. J., Gao W., McKee A., Lan M. S., Ullman M. D., Eisenhauer P. B., Fine R. E., Wells J. M., Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology Brain Research 2004 1022 1-2 164 172 (Pubitemid 39194996)
34. Pal R., Miranda M., Narayan M., Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention Biochemical and Biophysical Research Communications 2011 404 1 324 329
35. Wilson M. A., The role of cysteine oxidation in DJ-1 function and dysfunction Antioxidants and Redox Signaling 2011 15 1 111 122
36. Waak J., Weber S. S., Grner K., Schall C., Ichijo H., Stehle T., Kahle P. J., Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1 The Journal of Biological Chemistry 2009 284 21 14245 14257
37. Meng F., Yao D., Shi Y., Kabakoff J., Wu W., Reicher J., Ma Y., Moosmann B., Masliah E., Lipton S. A., Gu Z., Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation Molecular Neurodegeneration 2011 6 1, article 34
38. Wong E. S. P., Tan J. M. M., Wang C., Zhang Z., Tay S. P., Zaiden N., Han S. K., Dawson V. L., Dawson T. M., Lim K. L., Relative sensitivity of parkin and other cysteine-containing enzymes to stress-induced solubility alterations The Journal of Biological Chemistry 2007 282 16 12310 12318 (Pubitemid 47100679)
39. Kim J. R., Kwon K. S., Yoon H. W., Lee S. R., Rhee S. G., Oxidation of proteinaceous cysteine residues by dopamine-derived H 2 O 2 in PC12 cells Archives of Biochemistry and Biophysics 2002 397 2 414 423 (Pubitemid 34852311)
40. Kuhn D. M., Arthur R. E. Jr., Thomas D. M., Elferink L. A., Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease Journal of Neurochemistry 1999 73 3 1309 1317 (Pubitemid 29395493)
41. Sadidi M., Geddes T. J., Kuhn D. M., S-thiolation of tyrosine hydroxylase by reactive nitrogen species in the presence of cysteine or glutathione Antioxidants and Redox Signaling 2005 7 7-8 863 869 (Pubitemid 40967137)
42. Di Giovanni G., Pessia M., Di Maio R., Redox sensitivity of tyrosine hydroxylase activity and expression in dopaminergic dysfunction CNS Neurological Disorders: Drug Targets 2012 11 4 419 429
43. Walling A. D., Amyotrophic lateral sclerosis: lou Gehrig's disease American Family Physician 1999 59 6 1489 1496 (Pubitemid 29168667)
44. Longstreth W. T., Nelson L. M., Koepsell T. D., Van Belle G., Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis Medical Hypotheses 1991 34 2 144 148
45. Bosco D. A., Morfini G., Karabacak N. M., Song Y., Gros-Louis F., Pasinelli P., Goolsby H., Fontaine B. A., Lemay N., McKenna-Yasek D., Frosch M. P., Agar J. N., Julien J. P., Brady S. T., Brown R. H., Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS Nature Neuroscience 2010 13 11 1396 1403
46. Redler R. L., Wilcox K. C., Proctor E. A., Fee L., Caplow M., Dokholyan N. V., Glutathionylation at Cys-111 induces dissociation of wild type and FALS mutant SOD1 dimers Biochemistry 2011 50 32 7057 7066
47. Smith J. K., Patil C. N., Patlolla S., Gunter B. W., Booz G. W., Duhé R. J., Identification of a redox-sensitive switch within the JAK2 catalytic domain Free Radical Biology and Medicine 2012 52 6 1101 1110
48. Monroe R. K., Halvorsen S. W., Environmental toxicants inhibit neuronal Jak tyrosine kinase by mitochondrial disruption NeuroToxicology 2009 30 4 589 598
49. Haendeler J., Weiland U., Zeiher A. M., Dimmeler S., Effects of redox-related congeners of NO on apoptosis and caspase-3 activity Nitric Oxide 1997 1 4 282 293 (Pubitemid 28078115)
50. Liu L., Stamler J. S., NO: an inhibitor of cell death Cell Death and Differentiation 1999 6 10 937 942 (Pubitemid 29520793)
51. Melino G., Catani M. V., Corazzari M., Guerrieri P., Bernassola F., Nitric oxide can inhibit apoptosis or switch it into necrosis Cellular and Molecular Life Sciences 2000 57 4 612 622 (Pubitemid 30311432)
52. Adamczyk A., Kamierczak A., Czapski G. A., Strosznajder J. B., -Synuclein induced cell death in mouse hippocampal (HT22) cells is mediated by nitric oxide-dependent activation of caspase-3 FEBS Letters 2010 584 15 3504 3508
53. Kang Y. C., Kim P. K., Choi B. M., Chung H. T., Ha K. S., Kwon Y. G., Kim Y. M., Regulation of programmed cell death in neuronal cells by nitric oxide In Vivo 2004 18 3 367 376 (Pubitemid 39069753)
54. Numajiri N., Takasawa K., Nishiya T., Tanaka H., Ohno K., Hayakawa W., Asada M., Matsuda H., Azumi K., Kamata H., Nakamura T., Hara H., Minami M., Lipton S. A., Uehara T., On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN) Proceedings of the National Academy of Sciences of the United States of America 2011 108 25 10349 10354
55. Lee S. R., Yang K. S., Kwon J., Lee C., Jeong W., Rhee S. G., Reversible inactivation of the tumor suppressor PTEN by H 2 O 2 The Journal of Biological Chemistry 2002 277 23 20336 20342 (Pubitemid 34967328)
56. Cumming R. C., Schubert D., Amyloid- induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease FASEB Journal 2005 19 14 2060 2062 (Pubitemid 41759765)
57. Wang T., Tamae D., LeBon T., Shively J. E., Yen Y., Li J. J., The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells Cancer Research 2005 65 22 10338 10346 (Pubitemid 41748145)
58. Goplen D., Wang J., Enger P.., Tysnes B. B., Terzis A. J. A., Laerum O. D., Bjerkvig R., Protein disulfide isomerase expression is related to the invasive properties of malignant glioma Cancer Research 2006 66 20 9895 9902 (Pubitemid 44672041)
59. Jang H. S., Lal S., Greenwood J. A., Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2 Neurochemical Research 2010 35 11 1796 1804
60. Lal S., La Du J., Tanguay R. L., Greenwood J. A., Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment Journal of Neuroscience Research 2012 90 769 781
61. Clements C. M., McNally R. S., Conti B. J., Mak T. W., Ting J. P. Y., DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 Proceedings of the National Academy of Sciences of the United States of America 2006 103 41 15091 15096 (Pubitemid 44583169)
62. McNally R. S., Davis B. K., Clements C. M., Accavitti-Loper M. A., Mak T. W., Ting J. P. Y., DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF- B The Journal of Biological Chemistry 2011 286 6 4098 4106
63. Bertoni J. M., Arlette J. P., Fernandez H. H., Fitzer-Attas C., Frei K., Hassan M. N., Isaacson S. H., Lew M. F., Molho E., Ondo W. G., Phillips T. J., Singer C., Sutton J. P., Wolf J. E., Increased melanoma risk in Parkinson disease: a prospective clinicopathological study Archives of Neurology 2010 67 3 347 352
64. Fujiwara M., Marusawa H., Wang H. Q., Iwai A., Ikeuchi K., Imai Y., Kataoka A., Nukina N., Takahashi R., Chiba T., Parkin as a tumor suppressor gene for hepatocellular carcinoma Oncogene 2008 27 46 6002 6011
65. Poulogiannis G., McIntyre R. E., Dimitriadi M., Apps J. R., Wilson C. H., Ichimura K., Luo F., Cantley L. C., Wyllie A. H., Adams D. J., Arends M. J., PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice Proceedings of the National Academy of Sciences of the United States of America 2010 107 34 15145 15150
66. Kim Y. C., Kitaura H., Iguchi-Ariga S. M. M., Ariga H., DJ-1, an oncogene and causative gene for familial Parkinson's disease, is essential for SV40 transformation in mouse fibroblasts through up-regulation of c-Myc FEBS Letters 2010 584 18 3891 3895
67. Ren H., Fu K., Mu C., Li B., Wang D., Wang G., DJ-1, a cancer and Parkinson's disease associated protein, regulates autophagy through JNK pathway in cancer cells Cancer Letters 2010 297 1 101 108
68. Somwar R., Erdjument-Bromage H., Larsson E., Shum D., Lockwood W. W., Yang G., Sander C., Ouerfelli O., Tempst P. J., Djaballah H., Varmus H. E., Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines Proceedings of the National Academy of Sciences of the United States of America 2011 108 16375 16380
69. Joshi G., Aluise C. D., Cole M. P., Sultana R., Pierce W. M., Vore M., St Clair D. K., Butterfield D. A., Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain Neuroscience 2010 166 3 796 807